Drug intelligence / Profile preview

pyrrolidine dithiocarbamate

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal (preclinical/animal Studies)[7], Not Established For Human Clinical Use; Primarily Used In Research Settings.
01

Overview

Pyrrolidine dithiocarbamate (PDTC) is a small molecule compound belonging to the dithiocarbamate family. It acts as a metal chelator and has demonstrated antioxidant properties. PDTC is best known as an inhibitor of nuclear factor kappa B (NF-κB) signaling and also inhibits STAT3 activation. It can induce G1 phase cell cycle arrest and prevent induction of nitric oxide synthase. PDTC forms complexes with transition metals such as zinc, which can enter cells and inhibit viral RNA-dependent RNA polymerase activity[1][5][7]. In preclinical studies, it has shown anti-inflammatory effects, radical scavenging activity, and potential anticancer properties by reversing resistance to apoptosis in cancer cells overexpressing Bcl-xL protein[5]. Additionally, it has been investigated for its ability to attenuate cancer cachexia in animal models by modulating IL-6/STAT3/NF-κB pathways[7].

Other names
pyrrolidine-1-carbodithioic acidpyrrolidine1-carbodithioic acidpyrrolidine 1-carbodithioic acidpyrrolidinedithiocarbamateammonium pyrrolidinedithiocarbamateAPDTCAPDC
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)NOS1 (nNOS)NF-κB

Beyond the preview

Go deeper on pyrrolidine dithiocarbamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pyrrolidine dithiocarbamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call